Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2019

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2019
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2019
The figures have not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2019
30 Jun 2018
30 Jun 2019
30 Jun 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
145,466
123,991
295,852
257,250
2 Profit/(loss) before tax
18,316
12,915
37,102
26,170
3 Profit/(loss) for the period
13,916
10,339
28,381
20,986
4 Profit/(loss) attributable to ordinary equity holders of the parent
13,916
10,339
28,381
20,986
5 Basic earnings/(loss) per share (Subunit)
2.07
1.59
4.26
3.22
6 Proposed/Declared dividend per share (Subunit)
1.00
1.50
1.00
1.50


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.7600
0.7300

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 30 Aug 2019
Category Financial Results
Reference Number FRA-14082019-00018